Matrone M, Cuomo A, De Filippis S, Fagiolini A, Amore M
Drugs Context. 2024; 13.
PMID: 39624648
PMC: 11610565.
DOI: 10.7573/dic.2024-6-5.
Weng H, Zou W, Tian F, Xie H, Liu A, Liu W
Nat Commun. 2024; 15(1):6058.
PMID: 39025877
PMC: 11258261.
DOI: 10.1038/s41467-024-50312-1.
Garrote-Camara M, Juarez-Vela R, Rodriguez-Munoz P, Perez J, Sanchez-Gonzalez J, Rubinat-Arnaldo E
BMC Nurs. 2023; 22(1):292.
PMID: 37641035
PMC: 10464465.
DOI: 10.1186/s12912-023-01434-2.
Curry A, Malas N, Mroczkowski M, Hong V, Nordstrom K, Terrell C
Focus (Am Psychiatr Publ). 2023; 21(1):35-45.
PMID: 37205032
PMC: 10172538.
DOI: 10.1176/appi.focus.20220064.
Garrote-Camara M, Gea-Caballero V, Sufrate-Sorzano T, Rubinat-Arnaldo E, Santos-Sanchez J, Cobos-Rincon A
Int J Environ Res Public Health. 2022; 19(23).
PMID: 36498042
PMC: 9735933.
DOI: 10.3390/ijerph192315972.
Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed.
Citrome L, Risinger R, Rajachandran L, Robison H
Adv Ther. 2022; 39(10):4821-4835.
PMID: 36002761
PMC: 9464744.
DOI: 10.1007/s12325-022-02274-3.
Inhaled Loxapine as a Rapid Treatment for Agitation in Patients with Personality Disorder: A Prospective Study on the Effects of Time.
Ferrer M, Soto-Angona O, Soler-Artigas M, Ibanez P, Fadeuilhe C, Palma-Alvarez R
Clin Psychopharmacol Neurosci. 2022; 20(3):482-490.
PMID: 35879032
PMC: 9329112.
DOI: 10.9758/cpn.2022.20.3.482.
Assessment and Management of Agitation in Consultation-Liaison Psychiatry.
Raveesh B, Munoli R, Gowda G
Indian J Psychiatry. 2022; 64(Suppl 2):S484-S498.
PMID: 35602364
PMC: 9122159.
DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_22_22.
Sevoflurane Ameliorates Schizophrenia in a Mouse Model and Patients: A Pre-Clinical and Clinical Feasibility Study.
Zhao T, Shi Z, Ling N, Qin J, Zhou Q, Wu L
Curr Neuropharmacol. 2022; 20(12):2369-2380.
PMID: 35272593
PMC: 9890293.
DOI: 10.2174/1570159X20666220310115846.
Effect of Sublingual Dexmedetomidine vs Placebo on Acute Agitation Associated With Bipolar Disorder: A Randomized Clinical Trial.
Preskorn S, Zeller S, Citrome L, Finman J, Goldberg J, Fava M
JAMA. 2022; 327(8):727-736.
PMID: 35191924
PMC: 8864508.
DOI: 10.1001/jama.2022.0799.
The future of dry powder inhaled therapy: Promising or discouraging for systemic disorders?.
Ye Y, Ma Y, Zhu J
Int J Pharm. 2022; 614:121457.
PMID: 35026316
PMC: 8744475.
DOI: 10.1016/j.ijpharm.2022.121457.
Integrated Management of Multiple Sclerosis Spasticity and Associated Symptoms Using the Spasticity-Plus Syndrome Concept: Results of a Structured Specialists' Discussion Using the Workmat Methodology.
Fernandez O, Costa-Frossard L, Martinez-Gines M, Montero P, Prieto-Gonzalez J, Ramio-Torrenta L
Front Neurol. 2021; 12:722801.
PMID: 34646229
PMC: 8503561.
DOI: 10.3389/fneur.2021.722801.
The Management of Psychomotor Agitation Associated with Schizophrenia or Bipolar Disorder: A Brief Review.
Pompili M, Ducci G, Galluzzo A, Rosso G, Palumbo C, de Berardis D
Int J Environ Res Public Health. 2021; 18(8).
PMID: 33924111
PMC: 8074323.
DOI: 10.3390/ijerph18084368.
Distribution of agitation and related symptoms among hospitalized patients using a scalable natural language processing method.
Hart K, Pellegrini A, Forester B, Berretta S, Murphy S, Perlis R
Gen Hosp Psychiatry. 2020; 68:46-51.
PMID: 33310013
PMC: 7855889.
DOI: 10.1016/j.genhosppsych.2020.11.003.
Recognition and management of agitation in acute mental health services: a qualitative evaluation of staff perceptions.
Tucker J, Whitehead L, Palamara P, Rosman J, Seaman K
BMC Nurs. 2020; 19(1):106.
PMID: 33292208
PMC: 7653876.
DOI: 10.1186/s12912-020-00495-x.
Moving Towards Optimized Noncommunicable Disease Management in the ASEAN Region: Recommendations from a Review and Multidisciplinary Expert Panel.
Castillo-Carandang N, Buenaventura R, Chia Y, Do Van D, Lee C, Duong N
Risk Manag Healthc Policy. 2020; 13:803-819.
PMID: 32765135
PMC: 7371561.
DOI: 10.2147/RMHP.S256165.
Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults.
Faden J, Citrome L
Neuropsychiatr Dis Treat. 2019; 15:2273-2283.
PMID: 31496709
PMC: 6689540.
DOI: 10.2147/NDT.S173567.
Inhaled Loxapine for the Management of Acute Agitation in Bipolar Disorder and Schizophrenia: Expert Review and Commentary in an Era of Change.
Pacciardi B, Calcedo A, Messer T
Drugs R D. 2019; 19(1):15-25.
PMID: 30721526
PMC: 6380965.
DOI: 10.1007/s40268-019-0262-3.